{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:53:51Z","timestamp":1761490431271,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"VINS Bioproducts Ltd."},{"name":"Biogentech Co. Ltd."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.058","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T19:47:22Z","timestamp":1511812042000},"page":"285-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination"],"prefix":"10.1016","volume":"36","author":[{"given":"Jatuporn","family":"Sirikun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupin","family":"Suputtamongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ploypailin","family":"Rattanachinakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athiwat","family":"Primsirikunawut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.058_b0005","unstructured":"WHO Expert Consultation on Rabies. Second report. World Health Organization technical report series; 2013. p. 1\u2013139, back cover."},{"key":"10.1016\/j.vaccine.2017.11.058_b0010","doi-asserted-by":"crossref","first-page":"e0004902","DOI":"10.1371\/journal.pntd.0004902","article-title":"Post-exposure treatment with anti-rabies VHH and vaccine significantly improves protection of mice from lethal rabies infection","volume":"10","author":"Terryn","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"key":"10.1016\/j.vaccine.2017.11.058_b0015","first-page":"103","article-title":"Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons: part 3","volume":"25","author":"Atanasiu","year":"1961","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.11.058_b0020","doi-asserted-by":"crossref","unstructured":"Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Publ Health 2017;14.","DOI":"10.3390\/ijerph14040435"},{"key":"10.1016\/j.vaccine.2017.11.058_b0025","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","article-title":"The weight of obesity on the human immune response to vaccination","volume":"33","author":"Painter","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.058_b0030","doi-asserted-by":"crossref","unstructured":"Karlsson EA, Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S. Obesity outweighs protection conferred by adjuvanted influenza vaccination. mBio 2016;7:e01144-16.","DOI":"10.1128\/mBio.01144-16"},{"key":"10.1016\/j.vaccine.2017.11.058_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.03.008","article-title":"Obesity altered T cell metabolism and the response to infection","volume":"46","author":"Green","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.11.058_b0040","first-page":"461","article-title":"The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment","volume":"24","author":"Wasi","year":"1993","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"10.1016\/j.vaccine.2017.11.058_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08916930600597326","article-title":"Reduced tetanus antibody titers in overweight children","volume":"39","author":"Eliakim","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.vaccine.2017.11.058_b0050","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM198605223142119","article-title":"Impaired immunogenicity of hepatitis B vaccine in obese persons","volume":"314","author":"Weber","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.11.058_b0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0264-410X(95)00213-K","article-title":"What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?","volume":"14","author":"Khawplod","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.058_b0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(50)90224-5","article-title":"Use of hyperimmune anti-rabies serum concentrates in experimental rabies","volume":"8","author":"Koprowski","year":"1950","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2017.11.058_b0065","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1016\/j.vaccine.2009.09.036","article-title":"Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines","volume":"27","author":"Quiambao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.058_b0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4161\/hv.25431","article-title":"Feasibility of reducing rabies immunoglobulin dosage for passive immunization against rabies: results of in vitro and in vivo studies","volume":"9","author":"Madhusudana","year":"2013","journal-title":"Hum Vaccines Immunotherapeut"},{"key":"10.1016\/j.vaccine.2017.11.058_b0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/21645515.2016.1255834","article-title":"Injecting rabies immunoglobulin (RIG) into wounds only: a significant saving of lives and costly RIG","volume":"13","author":"Bharti","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.11.058_b0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/21645515.2015.1085142","article-title":"Local infiltration of rabies immunoglobulins without systemic intramuscular administration: an alternative cost effective approach for passive immunization against rabies","volume":"12","author":"Bharti","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.11.058_b0085","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","article-title":"Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies","volume":"5","author":"Niewiesk","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2017.11.058_b0090","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1016\/j.vaccine.2009.09.029","article-title":"Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals","volume":"27","author":"Rupprecht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.058_b0095","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recom Rep: Morbid Mortal Week Rep Recomm Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:50Z","timestamp":1759400630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17316225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17316225"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}